Omidria Injection, Solution, Concentrate
Product Images NDC 82604-600

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Omidria (NDC 82604-600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rayner Surgical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Omi00 0003 01)

Chemical structure of phenylephrine hydrochloride, showing a benzene ring with hydroxyl groups and an amino group attached, representing the active ingredient phenylephrine in Omidria injection solution.*

FDA Label Image

Figure 2 (Omi00 0003 02)

Chemical structure showing the molecular diagrams of phenylephrine and ketorolac, the active ingredients in Omidria injection solution concentrate by Rayner Surgical Inc.*

FDA Label Image

Figure 3 (Omi00 0003 03)

Line graphs from two clinical studies showing mean pupil diameter change (mm) from baseline over time in minutes since start of incision. Data compare Omidria injection solution with placebo, indicating pupil diameter remains closer to baseline with Omidria in both studies, while placebo shows a significant decrease.*

FDA Label Image

Figure 4 (Omi00 0003 04)

Two line graphs labeled Study 1 and Study 2 showing mean VAS scores (mm) over hours post surgery. Each graph compares Omidria and placebo groups, with Omidria group consistently having lower mean VAS scores over time. The x-axis denotes hours post surgery, and the y-axis shows mean VAS scores.*

FDA Label Image

Omi00-0003-05 (Omi00 0003 05)

Omidria injection solution carton label showing the product name, active ingredients phenylephrine and ketorolac at concentrations of 1% and 0.3% respectively, and usage information for intraocular injection. The label states the product is a single-patient vial, sterile 4 mL, quantity of 4, and manufactured for Rayner Surgical Inc. It includes storage instructions and a barcode. The label emphasizes the product must be diluted before use.*

FDA Label Image

Omi00-0003-06 (Omi00 0003 06)

Omidria 1% / 0.3% phenylephrine and ketorolac intraocular solution carton for single-patient use. The sterile 4 mL vial is labeled for intraocular injection and must be diluted. Manufactured by Rayner Surgical Inc., the label includes active ingredients concentrations and storage instructions. Barcodes and regulatory notes are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.